| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $28.0M | +80.3% |
| SG&A Expense | $51.6M | +613.0% |
| Operating Income | -$79.6M | -148.6% |
| Pre-tax Income | -$49.7M | -59.3% |
| Income Tax | $1.3M | +4920.0% |
| Net Income | -$51.0M | -341.9% |
| EPS (Basic) | -$0.18 | +64.7% |
| EPS (Diluted) | -$0.18 | +64.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.6M | — |
| Inventory | $383K | — |
| Current Assets | $396.6M | — |
| Total Assets | $440.4M | +59.1% |
| Current Liabilities | $19.4M | +2038.6% |
| Total Liabilities | $48.9M | +16.6% |
| Stockholders' Equity | $391.5M | +1051.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.5M | -1923.5% |
| Capital Expenditures | $14.7M | +63.7% |
| Investing Cash Flow | -$296.0M | -7.2% |
| Financing Cash Flow | $289.9M | +4.2% |
| Free Cash Flow | -$61.2M | -443.6% |